nodes	percent_of_prediction	percent_of_DWPC	metapath
Atropine—Ileus paralytic—Vincristine—muscle cancer	0.0264	0.0264	CcSEcCtD
Atropine—Speech impairment NOS—Methotrexate—muscle cancer	0.0254	0.0254	CcSEcCtD
Atropine—Blindness—Vincristine—muscle cancer	0.0206	0.0206	CcSEcCtD
Atropine—Paralysis—Vincristine—muscle cancer	0.0164	0.0164	CcSEcCtD
Atropine—Cyanosis—Etoposide—muscle cancer	0.0131	0.0131	CcSEcCtD
Atropine—Rash papular—Doxorubicin—muscle cancer	0.0129	0.0129	CcSEcCtD
Atropine—Supraventricular extrasystoles—Doxorubicin—muscle cancer	0.0129	0.0129	CcSEcCtD
Atropine—Laryngospasm—Etoposide—muscle cancer	0.0124	0.0124	CcSEcCtD
Atropine—Loss of libido—Methotrexate—muscle cancer	0.012	0.012	CcSEcCtD
Atropine—Retrosternal pain—Doxorubicin—muscle cancer	0.0119	0.0119	CcSEcCtD
Atropine—Sinus tachycardia—Doxorubicin—muscle cancer	0.0119	0.0119	CcSEcCtD
Atropine—Respiratory failure—Vincristine—muscle cancer	0.0116	0.0116	CcSEcCtD
Atropine—Coma—Vincristine—muscle cancer	0.0104	0.0104	CcSEcCtD
Atropine—Lethargy—Dactinomycin—muscle cancer	0.00946	0.00946	CcSEcCtD
Atropine—Skin exfoliation—Etoposide—muscle cancer	0.00882	0.00882	CcSEcCtD
Atropine—Blindness—Doxorubicin—muscle cancer	0.00866	0.00866	CcSEcCtD
Atropine—Rash maculo-papular—Etoposide—muscle cancer	0.0084	0.0084	CcSEcCtD
Atropine—Hyponatraemia—Vincristine—muscle cancer	0.00831	0.00831	CcSEcCtD
Atropine—Dysphagia—Dactinomycin—muscle cancer	0.00801	0.00801	CcSEcCtD
Atropine—Paralysis—Methotrexate—muscle cancer	0.00797	0.00797	CcSEcCtD
Atropine—Cardiac arrest—Vincristine—muscle cancer	0.00787	0.00787	CcSEcCtD
Atropine—Urinary retention—Vincristine—muscle cancer	0.00787	0.00787	CcSEcCtD
Atropine—Cyanosis—Methotrexate—muscle cancer	0.00782	0.00782	CcSEcCtD
Atropine—Ataxia—Vincristine—muscle cancer	0.00779	0.00779	CcSEcCtD
Atropine—Dehydration—Vincristine—muscle cancer	0.0077	0.0077	CcSEcCtD
Atropine—Swelling—Etoposide—muscle cancer	0.0076	0.0076	CcSEcCtD
Atropine—Stupor—Methotrexate—muscle cancer	0.00741	0.00741	CcSEcCtD
Atropine—Keratitis—Doxorubicin—muscle cancer	0.00739	0.00739	CcSEcCtD
Atropine—Paralysis—Doxorubicin—muscle cancer	0.0069	0.0069	CcSEcCtD
Atropine—Petechiae—Methotrexate—muscle cancer	0.00673	0.00673	CcSEcCtD
Atropine—Dysuria—Vincristine—muscle cancer	0.00669	0.00669	CcSEcCtD
Atropine—Laryngitis—Doxorubicin—muscle cancer	0.00665	0.00665	CcSEcCtD
Atropine—Erectile dysfunction—Vincristine—muscle cancer	0.00659	0.00659	CcSEcCtD
Atropine—Ventricular arrhythmia—Doxorubicin—muscle cancer	0.00648	0.00648	CcSEcCtD
Atropine—Speech disorder—Methotrexate—muscle cancer	0.00644	0.00644	CcSEcCtD
Atropine—Cardiac arrest—Etoposide—muscle cancer	0.00638	0.00638	CcSEcCtD
Atropine—Depression—Vincristine—muscle cancer	0.00636	0.00636	CcSEcCtD
Atropine—Acute coronary syndrome—Vincristine—muscle cancer	0.00629	0.00629	CcSEcCtD
Atropine—Rash erythematous—Doxorubicin—muscle cancer	0.00626	0.00626	CcSEcCtD
Atropine—Myocardial infarction—Vincristine—muscle cancer	0.00626	0.00626	CcSEcCtD
Atropine—Sweating—Vincristine—muscle cancer	0.00612	0.00612	CcSEcCtD
Atropine—Feeling hot—Doxorubicin—muscle cancer	0.00611	0.00611	CcSEcCtD
Atropine—Flushing—Dactinomycin—muscle cancer	0.00595	0.00595	CcSEcCtD
Atropine—Stinging—Doxorubicin—muscle cancer	0.00592	0.00592	CcSEcCtD
Atropine—Ageusia—Doxorubicin—muscle cancer	0.00592	0.00592	CcSEcCtD
Atropine—Dysarthria—Methotrexate—muscle cancer	0.00585	0.00585	CcSEcCtD
Atropine—Petechiae—Doxorubicin—muscle cancer	0.00583	0.00583	CcSEcCtD
Atropine—Dysphagia—Etoposide—muscle cancer	0.0058	0.0058	CcSEcCtD
Atropine—Blood disorder—Doxorubicin—muscle cancer	0.00574	0.00574	CcSEcCtD
Atropine—Hallucination—Vincristine—muscle cancer	0.0057	0.0057	CcSEcCtD
Atropine—Respiratory failure—Methotrexate—muscle cancer	0.00564	0.00564	CcSEcCtD
Atropine—Erythema—Dactinomycin—muscle cancer	0.00558	0.00558	CcSEcCtD
Atropine—Delirium—Doxorubicin—muscle cancer	0.00557	0.00557	CcSEcCtD
Atropine—Depressed level of consciousness—Methotrexate—muscle cancer	0.00534	0.00534	CcSEcCtD
Atropine—Ventricular extrasystoles—Doxorubicin—muscle cancer	0.00531	0.00531	CcSEcCtD
Atropine—Skin exfoliation—Methotrexate—muscle cancer	0.00528	0.00528	CcSEcCtD
Atropine—Acute coronary syndrome—Etoposide—muscle cancer	0.0051	0.0051	CcSEcCtD
Atropine—Dysarthria—Doxorubicin—muscle cancer	0.00507	0.00507	CcSEcCtD
Atropine—Myocardial infarction—Etoposide—muscle cancer	0.00507	0.00507	CcSEcCtD
Atropine—Coma—Methotrexate—muscle cancer	0.00506	0.00506	CcSEcCtD
Atropine—Mental disorder—Vincristine—muscle cancer	0.00502	0.00502	CcSEcCtD
Atropine—Pulmonary oedema—Methotrexate—muscle cancer	0.00493	0.00493	CcSEcCtD
Atropine—Ventricular tachycardia—Doxorubicin—muscle cancer	0.00479	0.00479	CcSEcCtD
Atropine—Injection site reaction—Doxorubicin—muscle cancer	0.00476	0.00476	CcSEcCtD
Atropine—Dermatitis contact—Doxorubicin—muscle cancer	0.00474	0.00474	CcSEcCtD
Atropine—Agitation—Vincristine—muscle cancer	0.00458	0.00458	CcSEcCtD
Atropine—Skin exfoliation—Doxorubicin—muscle cancer	0.00458	0.00458	CcSEcCtD
Atropine—Oedema—Dactinomycin—muscle cancer	0.00456	0.00456	CcSEcCtD
Atropine—Blood urea increased—Doxorubicin—muscle cancer	0.00452	0.00452	CcSEcCtD
Atropine—Vertigo—Vincristine—muscle cancer	0.00448	0.00448	CcSEcCtD
Atropine—Dry eye—Doxorubicin—muscle cancer	0.00443	0.00443	CcSEcCtD
Atropine—Coma—Doxorubicin—muscle cancer	0.00438	0.00438	CcSEcCtD
Atropine—Rash maculo-papular—Doxorubicin—muscle cancer	0.00436	0.00436	CcSEcCtD
Atropine—Convulsion—Vincristine—muscle cancer	0.00432	0.00432	CcSEcCtD
Atropine—Flushing—Etoposide—muscle cancer	0.00431	0.00431	CcSEcCtD
Atropine—Pulmonary oedema—Doxorubicin—muscle cancer	0.00427	0.00427	CcSEcCtD
Atropine—Hypertonia—Doxorubicin—muscle cancer	0.0042	0.0042	CcSEcCtD
Atropine—Lethargy—Methotrexate—muscle cancer	0.0041	0.0041	CcSEcCtD
Atropine—Oedema—Vincristine—muscle cancer	0.00407	0.00407	CcSEcCtD
Atropine—Anaphylactic shock—Vincristine—muscle cancer	0.00407	0.00407	CcSEcCtD
Atropine—Osteoarthritis—Methotrexate—muscle cancer	0.00402	0.00402	CcSEcCtD
Atropine—Dysgeusia—Etoposide—muscle cancer	0.00396	0.00396	CcSEcCtD
Atropine—Hyperhidrosis—Vincristine—muscle cancer	0.00393	0.00393	CcSEcCtD
Atropine—Fatigue—Dactinomycin—muscle cancer	0.00393	0.00393	CcSEcCtD
Atropine—Pain—Dactinomycin—muscle cancer	0.0039	0.0039	CcSEcCtD
Atropine—Eczema—Doxorubicin—muscle cancer	0.00387	0.00387	CcSEcCtD
Atropine—Eye pain—Doxorubicin—muscle cancer	0.00385	0.00385	CcSEcCtD
Atropine—Irritability—Methotrexate—muscle cancer	0.00384	0.00384	CcSEcCtD
Atropine—Hypotension—Vincristine—muscle cancer	0.0038	0.0038	CcSEcCtD
Atropine—Ataxia—Methotrexate—muscle cancer	0.00378	0.00378	CcSEcCtD
Atropine—Feeling abnormal—Dactinomycin—muscle cancer	0.00375	0.00375	CcSEcCtD
Atropine—Gastrointestinal pain—Dactinomycin—muscle cancer	0.00372	0.00372	CcSEcCtD
Atropine—Insomnia—Vincristine—muscle cancer	0.00368	0.00368	CcSEcCtD
Atropine—Vertigo—Etoposide—muscle cancer	0.00363	0.00363	CcSEcCtD
Atropine—Abdominal pain—Dactinomycin—muscle cancer	0.0036	0.0036	CcSEcCtD
Atropine—Body temperature increased—Dactinomycin—muscle cancer	0.0036	0.0036	CcSEcCtD
Atropine—Hypoglycaemia—Doxorubicin—muscle cancer	0.00357	0.00357	CcSEcCtD
Atropine—Loss of consciousness—Etoposide—muscle cancer	0.00355	0.00355	CcSEcCtD
Atropine—Lethargy—Doxorubicin—muscle cancer	0.00355	0.00355	CcSEcCtD
Atropine—Fatigue—Vincristine—muscle cancer	0.00351	0.00351	CcSEcCtD
Atropine—Convulsion—Etoposide—muscle cancer	0.0035	0.0035	CcSEcCtD
Atropine—Hyponatraemia—Doxorubicin—muscle cancer	0.00349	0.00349	CcSEcCtD
Atropine—Constipation—Vincristine—muscle cancer	0.00348	0.00348	CcSEcCtD
Atropine—Pain—Vincristine—muscle cancer	0.00348	0.00348	CcSEcCtD
Atropine—Osteoarthritis—Doxorubicin—muscle cancer	0.00348	0.00348	CcSEcCtD
Atropine—Chest pain—Etoposide—muscle cancer	0.00344	0.00344	CcSEcCtD
Atropine—Hypersensitivity—Dactinomycin—muscle cancer	0.00336	0.00336	CcSEcCtD
Atropine—Gastrointestinal pain—Vincristine—muscle cancer	0.00333	0.00333	CcSEcCtD
Atropine—Confusional state—Etoposide—muscle cancer	0.00332	0.00332	CcSEcCtD
Atropine—Cardiac arrest—Doxorubicin—muscle cancer	0.00331	0.00331	CcSEcCtD
Atropine—Anaphylactic shock—Etoposide—muscle cancer	0.0033	0.0033	CcSEcCtD
Atropine—Ataxia—Doxorubicin—muscle cancer	0.00327	0.00327	CcSEcCtD
Atropine—Asthenia—Dactinomycin—muscle cancer	0.00327	0.00327	CcSEcCtD
Atropine—Dysuria—Methotrexate—muscle cancer	0.00325	0.00325	CcSEcCtD
Atropine—Dehydration—Doxorubicin—muscle cancer	0.00324	0.00324	CcSEcCtD
Atropine—Tachycardia—Etoposide—muscle cancer	0.00322	0.00322	CcSEcCtD
Atropine—Abdominal pain—Vincristine—muscle cancer	0.00322	0.00322	CcSEcCtD
Atropine—Body temperature increased—Vincristine—muscle cancer	0.00322	0.00322	CcSEcCtD
Atropine—Erectile dysfunction—Methotrexate—muscle cancer	0.0032	0.0032	CcSEcCtD
Atropine—Dry skin—Doxorubicin—muscle cancer	0.00319	0.00319	CcSEcCtD
Atropine—Hyperhidrosis—Etoposide—muscle cancer	0.00319	0.00319	CcSEcCtD
Atropine—Hypokalaemia—Doxorubicin—muscle cancer	0.00317	0.00317	CcSEcCtD
Atropine—Diarrhoea—Dactinomycin—muscle cancer	0.00312	0.00312	CcSEcCtD
Atropine—Drowsiness—Methotrexate—muscle cancer	0.0031	0.0031	CcSEcCtD
Atropine—Depression—Methotrexate—muscle cancer	0.00309	0.00309	CcSEcCtD
Atropine—Hypotension—Etoposide—muscle cancer	0.00308	0.00308	CcSEcCtD
Atropine—Abdominal distension—Doxorubicin—muscle cancer	0.00303	0.00303	CcSEcCtD
Atropine—Conjunctivitis—Methotrexate—muscle cancer	0.00301	0.00301	CcSEcCtD
Atropine—Dysphagia—Doxorubicin—muscle cancer	0.00301	0.00301	CcSEcCtD
Atropine—Hypersensitivity—Vincristine—muscle cancer	0.003	0.003	CcSEcCtD
Atropine—Sweating—Methotrexate—muscle cancer	0.00297	0.00297	CcSEcCtD
Atropine—Dyspnoea—Etoposide—muscle cancer	0.00294	0.00294	CcSEcCtD
Atropine—Somnolence—Etoposide—muscle cancer	0.00293	0.00293	CcSEcCtD
Atropine—Angina pectoris—Doxorubicin—muscle cancer	0.00293	0.00293	CcSEcCtD
Atropine—Asthenia—Vincristine—muscle cancer	0.00292	0.00292	CcSEcCtD
Atropine—Vomiting—Dactinomycin—muscle cancer	0.0029	0.0029	CcSEcCtD
Atropine—Rash—Dactinomycin—muscle cancer	0.00287	0.00287	CcSEcCtD
Atropine—Fatigue—Etoposide—muscle cancer	0.00284	0.00284	CcSEcCtD
Atropine—Pain—Etoposide—muscle cancer	0.00282	0.00282	CcSEcCtD
Atropine—Constipation—Etoposide—muscle cancer	0.00282	0.00282	CcSEcCtD
Atropine—Dysuria—Doxorubicin—muscle cancer	0.00281	0.00281	CcSEcCtD
Atropine—Diarrhoea—Vincristine—muscle cancer	0.00278	0.00278	CcSEcCtD
Atropine—Feeling abnormal—Etoposide—muscle cancer	0.00272	0.00272	CcSEcCtD
Atropine—Hyperglycaemia—Doxorubicin—muscle cancer	0.00271	0.00271	CcSEcCtD
Atropine—Nausea—Dactinomycin—muscle cancer	0.00271	0.00271	CcSEcCtD
Atropine—Gastrointestinal pain—Etoposide—muscle cancer	0.0027	0.0027	CcSEcCtD
Atropine—Dizziness—Vincristine—muscle cancer	0.00269	0.00269	CcSEcCtD
Atropine—Drowsiness—Doxorubicin—muscle cancer	0.00268	0.00268	CcSEcCtD
Atropine—Urticaria—Etoposide—muscle cancer	0.00262	0.00262	CcSEcCtD
Atropine—Body temperature increased—Etoposide—muscle cancer	0.00261	0.00261	CcSEcCtD
Atropine—Abdominal pain—Etoposide—muscle cancer	0.00261	0.00261	CcSEcCtD
Atropine—Conjunctivitis—Doxorubicin—muscle cancer	0.00261	0.00261	CcSEcCtD
Atropine—Vomiting—Vincristine—muscle cancer	0.00259	0.00259	CcSEcCtD
Atropine—Sweating—Doxorubicin—muscle cancer	0.00257	0.00257	CcSEcCtD
Atropine—Rash—Vincristine—muscle cancer	0.00257	0.00257	CcSEcCtD
Atropine—Dermatitis—Vincristine—muscle cancer	0.00256	0.00256	CcSEcCtD
Atropine—Headache—Vincristine—muscle cancer	0.00255	0.00255	CcSEcCtD
Atropine—Bradycardia—Doxorubicin—muscle cancer	0.00245	0.00245	CcSEcCtD
Atropine—Mental disorder—Methotrexate—muscle cancer	0.00244	0.00244	CcSEcCtD
Atropine—Hypersensitivity—Etoposide—muscle cancer	0.00243	0.00243	CcSEcCtD
Atropine—Erythema—Methotrexate—muscle cancer	0.00242	0.00242	CcSEcCtD
Atropine—Nausea—Vincristine—muscle cancer	0.00242	0.00242	CcSEcCtD
Atropine—Dysgeusia—Methotrexate—muscle cancer	0.00237	0.00237	CcSEcCtD
Atropine—Asthenia—Etoposide—muscle cancer	0.00237	0.00237	CcSEcCtD
Atropine—Pruritus—Etoposide—muscle cancer	0.00233	0.00233	CcSEcCtD
Atropine—Vision blurred—Methotrexate—muscle cancer	0.00228	0.00228	CcSEcCtD
Atropine—Diarrhoea—Etoposide—muscle cancer	0.00226	0.00226	CcSEcCtD
Atropine—Flushing—Doxorubicin—muscle cancer	0.00223	0.00223	CcSEcCtD
Atropine—Dizziness—Etoposide—muscle cancer	0.00218	0.00218	CcSEcCtD
Atropine—Vertigo—Methotrexate—muscle cancer	0.00217	0.00217	CcSEcCtD
Atropine—Arrhythmia—Doxorubicin—muscle cancer	0.00215	0.00215	CcSEcCtD
Atropine—Mental disorder—Doxorubicin—muscle cancer	0.00211	0.00211	CcSEcCtD
Atropine—Convulsion—Methotrexate—muscle cancer	0.0021	0.0021	CcSEcCtD
Atropine—Vomiting—Etoposide—muscle cancer	0.0021	0.0021	CcSEcCtD
Atropine—Erythema—Doxorubicin—muscle cancer	0.0021	0.0021	CcSEcCtD
Atropine—Rash—Etoposide—muscle cancer	0.00208	0.00208	CcSEcCtD
Atropine—Dermatitis—Etoposide—muscle cancer	0.00208	0.00208	CcSEcCtD
Atropine—Headache—Etoposide—muscle cancer	0.00207	0.00207	CcSEcCtD
Atropine—Chest pain—Methotrexate—muscle cancer	0.00206	0.00206	CcSEcCtD
Atropine—Tension—Doxorubicin—muscle cancer	0.00206	0.00206	CcSEcCtD
Atropine—Dysgeusia—Doxorubicin—muscle cancer	0.00205	0.00205	CcSEcCtD
Atropine—Nervousness—Doxorubicin—muscle cancer	0.00203	0.00203	CcSEcCtD
Atropine—Confusional state—Methotrexate—muscle cancer	0.00199	0.00199	CcSEcCtD
Atropine—Anaphylactic shock—Methotrexate—muscle cancer	0.00197	0.00197	CcSEcCtD
Atropine—Vision blurred—Doxorubicin—muscle cancer	0.00197	0.00197	CcSEcCtD
Atropine—Nausea—Etoposide—muscle cancer	0.00196	0.00196	CcSEcCtD
Atropine—Agitation—Doxorubicin—muscle cancer	0.00193	0.00193	CcSEcCtD
Atropine—Hyperhidrosis—Methotrexate—muscle cancer	0.00191	0.00191	CcSEcCtD
Atropine—Vertigo—Doxorubicin—muscle cancer	0.00188	0.00188	CcSEcCtD
Atropine—Syncope—Doxorubicin—muscle cancer	0.00188	0.00188	CcSEcCtD
Atropine—Palpitations—Doxorubicin—muscle cancer	0.00185	0.00185	CcSEcCtD
Atropine—Hypotension—Methotrexate—muscle cancer	0.00185	0.00185	CcSEcCtD
Atropine—Loss of consciousness—Doxorubicin—muscle cancer	0.00184	0.00184	CcSEcCtD
Atropine—Convulsion—Doxorubicin—muscle cancer	0.00182	0.00182	CcSEcCtD
Atropine—Insomnia—Methotrexate—muscle cancer	0.00179	0.00179	CcSEcCtD
Atropine—Chest pain—Doxorubicin—muscle cancer	0.00178	0.00178	CcSEcCtD
Atropine—Anxiety—Doxorubicin—muscle cancer	0.00178	0.00178	CcSEcCtD
Atropine—Dyspnoea—Methotrexate—muscle cancer	0.00176	0.00176	CcSEcCtD
Atropine—Somnolence—Methotrexate—muscle cancer	0.00176	0.00176	CcSEcCtD
Atropine—Dry mouth—Doxorubicin—muscle cancer	0.00174	0.00174	CcSEcCtD
Atropine—Dyspepsia—Methotrexate—muscle cancer	0.00174	0.00174	CcSEcCtD
Atropine—Confusional state—Doxorubicin—muscle cancer	0.00172	0.00172	CcSEcCtD
Atropine—Anaphylactic shock—Doxorubicin—muscle cancer	0.00171	0.00171	CcSEcCtD
Atropine—Oedema—Doxorubicin—muscle cancer	0.00171	0.00171	CcSEcCtD
Atropine—Fatigue—Methotrexate—muscle cancer	0.0017	0.0017	CcSEcCtD
Atropine—Pain—Methotrexate—muscle cancer	0.00169	0.00169	CcSEcCtD
Atropine—Shock—Doxorubicin—muscle cancer	0.00168	0.00168	CcSEcCtD
Atropine—Tachycardia—Doxorubicin—muscle cancer	0.00167	0.00167	CcSEcCtD
Atropine—Hyperhidrosis—Doxorubicin—muscle cancer	0.00165	0.00165	CcSEcCtD
Atropine—Feeling abnormal—Methotrexate—muscle cancer	0.00163	0.00163	CcSEcCtD
Atropine—Gastrointestinal pain—Methotrexate—muscle cancer	0.00161	0.00161	CcSEcCtD
Atropine—Hypotension—Doxorubicin—muscle cancer	0.0016	0.0016	CcSEcCtD
Atropine—Urticaria—Methotrexate—muscle cancer	0.00157	0.00157	CcSEcCtD
Atropine—Body temperature increased—Methotrexate—muscle cancer	0.00156	0.00156	CcSEcCtD
Atropine—Abdominal pain—Methotrexate—muscle cancer	0.00156	0.00156	CcSEcCtD
Atropine—Insomnia—Doxorubicin—muscle cancer	0.00155	0.00155	CcSEcCtD
Atropine—Dyspnoea—Doxorubicin—muscle cancer	0.00152	0.00152	CcSEcCtD
Atropine—Somnolence—Doxorubicin—muscle cancer	0.00152	0.00152	CcSEcCtD
Atropine—Dyspepsia—Doxorubicin—muscle cancer	0.00151	0.00151	CcSEcCtD
Atropine—Fatigue—Doxorubicin—muscle cancer	0.00147	0.00147	CcSEcCtD
Atropine—Pain—Doxorubicin—muscle cancer	0.00146	0.00146	CcSEcCtD
Atropine—Constipation—Doxorubicin—muscle cancer	0.00146	0.00146	CcSEcCtD
Atropine—Hypersensitivity—Methotrexate—muscle cancer	0.00145	0.00145	CcSEcCtD
Atropine—Asthenia—Methotrexate—muscle cancer	0.00142	0.00142	CcSEcCtD
Atropine—Feeling abnormal—Doxorubicin—muscle cancer	0.00141	0.00141	CcSEcCtD
Atropine—Gastrointestinal pain—Doxorubicin—muscle cancer	0.0014	0.0014	CcSEcCtD
Atropine—Pruritus—Methotrexate—muscle cancer	0.0014	0.0014	CcSEcCtD
Atropine—Urticaria—Doxorubicin—muscle cancer	0.00136	0.00136	CcSEcCtD
Atropine—Body temperature increased—Doxorubicin—muscle cancer	0.00135	0.00135	CcSEcCtD
Atropine—Abdominal pain—Doxorubicin—muscle cancer	0.00135	0.00135	CcSEcCtD
Atropine—Diarrhoea—Methotrexate—muscle cancer	0.00135	0.00135	CcSEcCtD
Atropine—Dizziness—Methotrexate—muscle cancer	0.00131	0.00131	CcSEcCtD
Atropine—Hypersensitivity—Doxorubicin—muscle cancer	0.00126	0.00126	CcSEcCtD
Atropine—Vomiting—Methotrexate—muscle cancer	0.00126	0.00126	CcSEcCtD
Atropine—Rash—Methotrexate—muscle cancer	0.00125	0.00125	CcSEcCtD
Atropine—Dermatitis—Methotrexate—muscle cancer	0.00124	0.00124	CcSEcCtD
Atropine—Headache—Methotrexate—muscle cancer	0.00124	0.00124	CcSEcCtD
Atropine—Asthenia—Doxorubicin—muscle cancer	0.00123	0.00123	CcSEcCtD
Atropine—Pruritus—Doxorubicin—muscle cancer	0.00121	0.00121	CcSEcCtD
Atropine—Nausea—Methotrexate—muscle cancer	0.00117	0.00117	CcSEcCtD
Atropine—Diarrhoea—Doxorubicin—muscle cancer	0.00117	0.00117	CcSEcCtD
Atropine—Dizziness—Doxorubicin—muscle cancer	0.00113	0.00113	CcSEcCtD
Atropine—Vomiting—Doxorubicin—muscle cancer	0.00109	0.00109	CcSEcCtD
Atropine—Rash—Doxorubicin—muscle cancer	0.00108	0.00108	CcSEcCtD
Atropine—Dermatitis—Doxorubicin—muscle cancer	0.00108	0.00108	CcSEcCtD
Atropine—Headache—Doxorubicin—muscle cancer	0.00107	0.00107	CcSEcCtD
Atropine—Nausea—Doxorubicin—muscle cancer	0.00102	0.00102	CcSEcCtD
